Jacksonville, FL – (December 4, 2015) – The American Association of Clinical Endocrinologists (AACE) today announced its Consensus Conference on Continuous Glucose Monitoring (CGM) slated for Saturday, February 20, 2016 at the Hyatt Regency Capitol Hill in Washington, D.C.
The Consensus Conference is being organized to identify the evidence supporting the development of clinical recommendations for the management of patients with diabetes using CGM technology.
There is a growing body of clinical evidence that demonstrates the effectiveness of CGM in the management of diabetes and improved outcomes. Advances in CGM technology support expanded use in new patient populations.
This conference will assemble a group of leaders representing stakeholders in the diabetes technology arena including medical, scientific, and professional societies; patient and lay organizations; government; large employers; medical device industry representatives and payers, to consider gaps in knowledge and practice with use of CGM in clinical practice. During the Conference, the following will be addressed:
- Identification of patient populations who may benefit from personal and/or professional CGM use;
- Standardization of CGM reporting to facilitate consistent interpretation in clinical practice;
- Definition of a protocol for effective analysis of CGM data for clinical utilization;
- Impact of using CGM to reduce healthcare costs associated with diabetes (e.g. severe hypoglycemic events);
- Mechanisms to remove barriers for successful use of professional and personal CGM by patients and healthcare providers for improved diabetes management, and
- Use of CGM in the evolving healthcare environment, (e.g. PCMH, alternative payment).
At the conclusion, a designated writing committee consisting of AACE member experts will prepare and publish a Consensus Statement that will be published in Endocrine Practice at a later date.
About the American Association of Clinical Endocrinologists (AACE)
The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Diabetes, Endocrinology and Metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our website at www.aace.com.
About the American College of Endocrinology (ACE)
The American College of Endocrinology (ACE) is the charitable, educational and scientific arm of the American Association of Clinical Endocrinologists (AACE). ACE is the leader in advancing the care and prevention of endocrine and metabolic disorders by: providing professional education and reliable public health information; recognizing excellence in education, research and service; promoting clinical research and defining the future of Clinical Endocrinology. For more information, please visit http://www.aace.com/college/.